Curaleaf Reports Strong Q4 2025 Results Amid Strategic Business Changes

Curaleaf Holdings Finishes Strong in Q4 2025

Curaleaf Holdings, Inc., a key player in the cannabis industry, has recently disclosed its preliminary financial results for the fourth quarter of 2025, showcasing impressive growth and stability amid significant strategic shifts. The company's net revenue for Q4 is projected to be no less than $330 million, which reflects a sequential increase of about 4% compared to Q3 2025. Notably, this marks a 1% growth from the previous year's Q4 revenue of $327.8 million.

Strategic Business Adjustments

In light of recent changes in federal legislation regarding hemp-derived products, Curaleaf has made the strategic decision to discontinue its hemp business and exit the Missouri market. These two segments had collectively contributed approximately $2 million in revenue during the previous quarters. The company’s Chairman and CEO, Boris Jordan, remarked on how these decisions are part of their broader aim to streamline operations and enhance profitability.

Gross Profit Margins

For the fourth quarter, the adjusted gross profit margin—excluding revenues from discontinued businesses—is expected to be around 48.5%. This mirrors the adjusted gross profit margin from Q4 2024 and indicates a robust performance amidst operational changes. The full year adjusted gross margin for 2025 is anticipated to reach around 50%, affirming Curaleaf's commitment to maintaining financial health and product quality.

“Return to Our Roots” Strategy

Curaleaf attributes its promising Q4 results to its “Return to Our Roots” strategy, aimed at focusing on core competencies and enhancing customer experiences. With a solid foundation now established, the company aims to foster renewed growth and performance as it moves into 2026. Jordan asserts that this strategy has effectively set the stage for future advances while ensuring that they maintain a resilient balance sheet. The company is also taking steps to refinance its senior secured notes that are due in December 2026, a move viewed as strategically important in navigating the evolving market landscape.

Looking Ahead

Curaleaf is scheduled to release its comprehensive financial and operational results for both Q4 and the entire year of 2025 in early March. Following this, an earnings conference call and audio webcast will take place to discuss the details. Stakeholders can expect insights into how Curaleaf plans to leverage its recent progress moving forward. Access to the earnings call information and further details will be available on the company’s investor relations website.

As a leading provider of cannabis consumer products, Curaleaf emphasizes its mission to enhance lives through quality products. The company operates under well-known brands such as Curaleaf, Select, and Grassroots, among others, ensuring top-tier service and product availability across both medicinal and recreational markets. Curaleaf’s comprehensive network extends internationally, addressing the rising demand for cannabis products through innovative cultivation and production methods.

Curaleaf Holdings, Inc. is publicly traded on the Toronto Stock Exchange under the symbol CURA and on the OTCQX market as CURLF, marking it as a notable player in the cannabis sector. The company's continued focus on quality, expertise, and operational effectiveness positions it favorably for sustained growth in the competitive cannabis marketplace.